ProciseDx Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
ProciseDx General Information
Description
Developer of diagnostics instruments designed to provide enhanced decisions. The company develops and commercializes a broad portfolio of point-of-care diagnostic tests for use in physician offices, retail clinics and urgent care, enabling physicians to answer patients using real-time lab-quality results.
Contact Information
Website
www.procisedx.com(Operating Subsidiary)
Corporate Office
- 9449 Carroll Park Drive
- San Diego, CA 92121
- United States
Corporate Office
- 9449 Carroll Park Drive
- San Diego, CA 92121
- United States
ProciseDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 09-Jun-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 15-Jun-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 21-Jul-2020 | $10.5M | $10.5M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-May-2020 | Completed | Startup |
ProciseDx Comparisons
Industry
Financing
Details
ProciseDx Competitors (4)
One of ProciseDx’s 4 competitors is Truvian, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Truvian | Venture Capital-Backed | San Diego, CA | ||||
| Orasure Technologies | Corporate Backed or Acquired | Bethlehem, PA | ||||
| QuantuMDx | Venture Capital-Backed | Newcastle Upon Tyne, United Kingdom | ||||
| QuidelOrtho | Corporation | San Diego, CA |
ProciseDx Patents
ProciseDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230160906-A1 | Detection of anti-tnf alpha drug biologics and anti-drug antibodies | Pending | 19-Nov-2021 | ||
| US-20230108128-A1 | Predetermined calibration curve | Inactive | 28-May-2020 | ||
| WO-2021242725-A1 | Predetermined calibration curve | Inactive | 28-May-2020 | ||
| US-20230131780-A1 | Methods of detecting antibodies to sars-cov-2 | Inactive | 30-Apr-2020 | ||
| WO-2021222533-A1 | Methods of detecting antibodies to sars-cov-2 | Inactive | 30-Apr-2020 | G01N33/56983 |
ProciseDx Signals
ProciseDx Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ALMA Life Sciences | Venture Capital | Minority | ||
| Biobrit | Venture Capital | Minority | ||
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Nestlé Health Science | Corporation | Minority |
ProciseDx FAQs
-
When was ProciseDx founded?
ProciseDx was founded in 2019.
-
Where is ProciseDx headquartered?
ProciseDx is headquartered in San Diego, CA.
-
What is the size of ProciseDx?
ProciseDx has 20 total employees.
-
What industry is ProciseDx in?
ProciseDx’s primary industry is Diagnostic Equipment.
-
Is ProciseDx a private or public company?
ProciseDx is a Private company.
-
What is ProciseDx’s current revenue?
The current revenue for ProciseDx is .
-
How much funding has ProciseDx raised over time?
ProciseDx has raised $27.5M.
-
Who are ProciseDx’s investors?
ALMA Life Sciences, Biobrit, CONNECT (San Diego), and Nestlé Health Science have invested in ProciseDx.
-
Who are ProciseDx’s competitors?
Truvian, Orasure Technologies, QuantuMDx, and QuidelOrtho are competitors of ProciseDx.
-
When was ProciseDx acquired?
ProciseDx was acquired on 09-Jun-2023.
-
Who acquired ProciseDx?
ProciseDx was acquired by Biosynex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process